Literature DB >> 17547834

NASH and the risk of cirrhosis and hepatocellular carcinoma in type 2 diabetes.

Elisabetta Bugianesi1, Ester Vanni, Giulio Marchesini.   

Abstract

The risk of chronic liver disease and liver-related mortality is increased in patients with type 2 diabetes mellitus. Several cohort studies have suggested a metabolic pathway from nonalcoholic fatty liver, nonalcoholic steatohepatitis, cryptogenic cirrhosis, and eventually hepatocellular carcinoma. Although cardiovascular risk remains the major cause for excess mortality in type 2 diabetes mellitus, the risk of progressive liver disease should no longer be underscored.

Entities:  

Mesh：

Year:  2007        PMID： 17547834     DOI： 10.1007/s11892-007-0029-z

Source DB:  PubMed          Journal:  Curr Diab Rep        ISSN： 1534-4827            Impact factor:   4.810


  50 in total

1.  Liver fibrosis in overweight patients.

Authors:  V Ratziu; P Giral; F Charlotte; E Bruckert; V Thibault; I Theodorou; L Khalil; G Turpin; P Opolon; T Poynard
Journal:  Gastroenterology       Date:  2000-06       Impact factor: 22.682

2.  Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese.

Authors:  J B Dixon; P S Bhathal; P E O'Brien
Journal:  Gastroenterology       Date:  2001-07       Impact factor: 22.682

3.  Nonalcoholic fatty liver disease and risk of future cardiovascular events among type 2 diabetic patients.

Authors:  Giovanni Targher; Lorenzo Bertolini; Felice Poli; Stefano Rodella; Luca Scala; Roberto Tessari; Luciano Zenari; Giancarlo Falezza
Journal:  Diabetes       Date:  2005-12       Impact factor: 9.461

4.  Prevalence of and risk factors for hepatic steatosis in Northern Italy.

Authors:  S Bellentani; G Saccoccio; F Masutti; L S Crocè; G Brandi; F Sasso; G Cristanini; C Tiribelli
Journal:  Ann Intern Med       Date:  2000-01-18       Impact factor: 25.391

5.  Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome.

Authors:  Giulio Marchesini; Elisabetta Bugianesi; Gabriele Forlani; Fernanda Cerrelli; Marco Lenzi; Rita Manini; Stefania Natale; Ester Vanni; Nicola Villanova; Nazario Melchionda; Mario Rizzetto
Journal:  Hepatology       Date:  2003-04       Impact factor: 17.425

6.  Prevalence of obesity and diabetes in patients with cryptogenic cirrhosis: a case-control study.

Authors:  A Poonawala; S P Nair; P J Thuluvath
Journal:  Hepatology       Date:  2000-10       Impact factor: 17.425

7.  Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults.

Authors:  Eugenia E Calle; Carmen Rodriguez; Kimberly Walker-Thurmond; Michael J Thun
Journal:  N Engl J Med       Date:  2003-04-24       Impact factor: 91.245

8.  Non-alcoholic steatohepatitis in type 2 diabetes mellitus.

Authors:  Parijat Gupte; Deepak Amarapurkar; Subhash Agal; Rajiv Baijal; Pramod Kulshrestha; Snehansu Pramanik; Nikhil Patel; Aruna Madan; Anjali Amarapurkar
Journal:  J Gastroenterol Hepatol       Date:  2004-08       Impact factor: 4.029

9.  Long-term outcomes of cirrhosis in nonalcoholic steatohepatitis compared with hepatitis C.

Authors:  Jason M Hui; James G Kench; Shivakumar Chitturi; Archana Sud; Geoffrey C Farrell; Karen Byth; Pauline Hall; Mahbub Khan; Jacob George
Journal:  Hepatology       Date:  2003-08       Impact factor: 17.425

10.  Prognostic significance of diabetes in patients with cirrhosis.

Authors:  G Bianchi; G Marchesini; M Zoli; E Bugianesi; A Fabbri; E Pisi
Journal:  Hepatology       Date:  1994-07       Impact factor: 17.425
View more
  20 in total

1.  Primary biliary cirrhosis-associated hepatocellular carcinoma in Chinese patients: incidence and risk factors.

Authors:  Xue-Xiu Zhang; Li-Feng Wang; Lei Jin; Yuan-Yuan Li; Shu-Li Hao; Yan-Chao Shi; Qing-Lei Zeng; Zhi-Wei Li; Zheng Zhang; George Kk Lau; Fu-Sheng Wang
Journal:  World J Gastroenterol       Date:  2015-03-28       Impact factor: 5.742

2.  An Endocrine Perspective of Nonalcoholic Fatty Liver Disease (NAFLD).

Authors:  Romina Lomonaco; Janet Chen; Kenneth Cusi
Journal:  Ther Adv Endocrinol Metab       Date:  2011-10       Impact factor: 3.565

3.  Polyol accumulation in muscle and liver in a mouse model of type 2 diabetes.

Authors:  Emily J Gallagher; Derek LeRoith; Marilyn Stasinopoulos; Zara Zelenko; Joseph Shiloach
Journal:  J Diabetes Complications       Date:  2016-04-27       Impact factor: 2.852

4.  Nonalcoholic fatty liver disease and microvascular complications in type 2 diabetes.

Authors:  Wen-Shan Lv; Rui-Xia Sun; Yan-Yan Gao; Jun-Ping Wen; Rong-Fang Pan; Li Li; Jing Wang; Yu-Xin Xian; Cai-Xia Cao; Ming Zheng
Journal:  World J Gastroenterol       Date:  2013-05-28       Impact factor: 5.742

5.  Abnormalities in carbohydrate and lipid metabolisms in high-fructose dietfed insulin-resistant rats: amelioration by Catharanthus roseus treatments.

Authors:  Karuna Rasineni; Ramesh Bellamkonda; Sreenivasa Reddy Singareddy; Saralakumari Desireddy
Journal:  J Physiol Biochem       Date:  2013-01-22       Impact factor: 4.158

6.  Synergism between obesity and alcohol in increasing the risk of hepatocellular carcinoma: a prospective cohort study.

Authors:  Rohit Loomba; Hwai-I Yang; Jun Su; David Brenner; Elizabeth Barrett-Connor; Uchenna Iloeje; Chien-Jen Chen
Journal:  Am J Epidemiol       Date:  2013-01-24       Impact factor: 4.897

7.  Inhibition of Glutaminyl Cyclases alleviates CCL2-mediated inflammation of non-alcoholic fatty liver disease in mice.

Authors:  Holger Cynis; Astrid Kehlen; Monique Haegele; Torsten Hoffmann; Ulrich Heiser; Masato Fujii; Yuichiro Shibazaki; Hiroyuki Yoneyama; Stephan Schilling; Hans-Ulrich Demuth
Journal:  Int J Exp Pathol       Date:  2013-04-08       Impact factor: 1.925

8.  The association between obstructive sleep apnea and non-alcoholic steatohepatitis: a retrospective nationwide inpatient sample analysis.

Authors:  Anas Renno; Yousef Abdel-Aziz; Yaseen Alastal; Sadik Khuder; Syed Hasan; Ragheb Assaly; Ali Nawras
Journal:  Clin Exp Hepatol       Date:  2021-03-25

9.  Effect of dietary advanced glycation end products on mouse liver.

Authors:  Raza Patel; Susan S Baker; Wensheng Liu; Sonal Desai; Razan Alkhouri; Rafal Kozielski; Lucy Mastrandrea; Adil Sarfraz; Weijing Cai; Helen Vlassara; Mulchand S Patel; Robert D Baker; Lixin Zhu
Journal:  PLoS One       Date:  2012-04-04       Impact factor: 3.240

Review 10.  Biomarkers in Hepatobiliary Cancers: What is Useful in Clinical Practice?

Authors:  Alice Boilève; Marc Hilmi; Matthieu Delaye; Annemilaï Tijeras-Raballand; Cindy Neuzillet
Journal:  Cancers (Basel)       Date:  2021-05-30       Impact factor: 6.639
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.